(INCY:Consolidated Issue Listed on NASDAQ Global Select )
Reid M. Huber Ph.D.
Chief Scientific Officer and Executive Vice President, Incyte Corporation
|Age||Total Calculated Compensation||This person is connected to 10 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Dr. Reid M. Huber, Ph.D. serves as the Chief Scientific Officer and Executive Vice President of Incyte Corporation. Dr. Huber leads drug discovery research primarily in the area of hematology/oncology. He served as Senior Vice President of Discovery Biology at Incyte Corporation. He was a founding member of the team that started drug discovery at Incyte Corporation in 2002. Dr. Huber joined Incyte in January 2002 as an Associate Director of Applied Technology. For nine ...
1801 Augustine Cut-OffPhone: 302-498-6700
Wilmington, Delaware 19803
Board Members Memberships*
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Washington University, St. Louis
Murray State University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Harvey J. Berger M.D.||Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Ariad Pharmaceuticals Inc.
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma, Inc.
|Werner Lanthaler MBA,MPA||Chief Executive Officer and Member of Management Board|
|Adelene Q. Perkins||Chairman of The Board, Chief Executive Officer and President|
Infinity Pharmaceuticals, Inc.
|Amr Mamdouh Abdel Majid||Chairman of the Board and Managing Director|
|--||Compensation as of Fiscal Year 2013.|